• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT311417J
Device Problems Complete Blockage (1094); No Apparent Adverse Event (3189)
Patient Problems Occlusion (1984); Thrombus (2101); No Consequences Or Impact To Patient (2199)
Event Date 05/08/2020
Event Type  Injury  
Manufacturer Narrative
The plc121400j lot # 21347840 udi:(b)(4) is being reported under mfr report # 3013164176-2020-00072.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to occlusion of the device or native vessel.
 
Event Description
The following was reported to gore; on (b)(6) 2020, a patient underwent endovascular treatment of an abdominal aortic dissection using a gore® excluder® aaa endoprostheses and gore® excluder® iliac branch endoprostheses.On (b)(6) 2020, the patient complained the right limb pain.The ct imaged identified that the gore® excluder® aaa endoprostheses implanted in the right limb were occluded with thrombus.The physician attempted to address the occlusion using an endovascular technique, but the guide wire couldn¿t be delivered to the lesion.The physician abandoned the endovascular technique.A femoral ¿ femoral bypass was created.The patient tolerated the procedure.The physician stated that the lumen of endoprosthesis became narrow because the right external iliac artery was tortuous, and this led to the thrombus occlusion of the right limb.
 
Manufacturer Narrative
Additional information was received indicating the rlt311417j lot # 21363716 was not occluded.Medwatch # 3007284313-2020-00134 was sent in error.Additional received information determined that this event is not reportable to the fda and therefore the medwatch will be retracted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10084645
MDR Text Key193303744
Report Number3007284313-2020-00134
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 06/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/19/2022
Device Catalogue NumberRLT311417J
Device Lot Number21363716
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age71 YR
-
-